• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX INC. BACT/ALERT FA PLUS; BACT/ALERT® FA PLUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX INC. BACT/ALERT FA PLUS; BACT/ALERT® FA PLUS Back to Search Results
Catalog Number 410851
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem Misdiagnosis (2159)
Event Type  Injury  
Event Description
A customer in (b)(6) notified biomérieux of post bottle inoculation contamination for a patient in association with the bact/alert® fa plus blood culture bottles (ref.410851, lot 4054200).Patient: female cancer patient receiving chemotherapy.A result of an oxidase positive gram-negative bacillus was provided to the treating physician.The patient was given preventative treatment and an antibiogram was done.Pcr was performed on the impacted patient bottles; all bottles obtained an identification of advenella kasmirensis.Biomérieux customer service confirmed advenella kasmirensis is an environmental organism.There is adverse patient impact; the patient received preventative treatment based upon an erroneous test result.A biomérieux internal investigation will be initiated.
 
Manufacturer Narrative
A customer in france notified biomérieux of post bottle inoculation contamination associated with the bact/alert® fa plus blood culture bottles (ref.(b)(4), lot 4054200) while testing a sample from a female cancer patient receiving chemotherapy.In response to the customer compliant, biomérieux conducted an internal investigation.Three hundred retained bottles from lot 4054200 were inspected, no cloudy or turbid bottles were found.Biomérieux reviewed the manufacturing batch records, packaging defect log, and final aql inspection results associated with lot 4054200, and found no anomalies during manufacturing that would cause or contribute to bottle contamination.Lot 4054200 met all quality finished goods release criteria.The bact/alert bottles undergo a steam-based autoclave process during manufacturing.All autoclave cycles have an exposure temperature of 121° c.The organism in this complaint would be killed by this autoclave cycle.Review of the bact/alert® fa plus blood culture bottle package insert confirmed there are sufficient instructions to the customer about how to visually inspect the bottle before use and precautions to warning that precautions must be taken to prevent contamination of the patient sample during both venipuncture and inoculation into the culture bottle.The root cause of the contamination result obtained by the customer could not be determined.The most likely root cause is that the contaminant entered the bottle at the time the bottle was inoculated with the sample (from the environment or other materials used in the blood culture collection).The instrument times to detection (ttd) support this root cause.Refer to section h10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BACT/ALERT FA PLUS
Type of Device
BACT/ALERT® FA PLUS
Manufacturer (Section D)
BIOMERIEUX INC.
100 rodolphe street
durham NC 27712
MDR Report Key9861374
MDR Text Key186598746
Report Number3002769706-2020-00003
Device Sequence Number1
Product Code MDB
UDI-Device Identifier03573026357900
UDI-Public03573026357900
Combination Product (y/n)N
PMA/PMN Number
K121461
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 10/23/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/14/2020
Device Catalogue Number410851
Device Lot Number4054200
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/17/2020
Initial Date FDA Received03/20/2020
Supplement Dates Manufacturer Received09/29/2020
Supplement Dates FDA Received10/23/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-